Telomir Pharmaceuticals, Inc. Common StockTELONASDAQ

Revenue (LTM)

Net Income (LTM)

$-10M

+37.0% YoY

Free Cash Flow

$-4M

Revenue CAGR (5Y)

—

—Marginsstable

FCF($0.0B)

Unprofitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	0	0	0	0	0
Gross Profit	0	0	0	0	0
Operating Income	-0	-1↓518.4%	-4↓361.5%	-12↓210.6%	-11↑13.9%
Net Income	-0	-1↓518.4%	-13↓1430.4%	-17↓26.5%	-10↑37.0%
EBITDA	0	0	-11	0↑100.4%	-11↓22055.9%
EPS Diluted	-0.00	-0.03↓512.8%	-0.44↓1427.8%	-0.56↓27.3%	-0.33↑41.1%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	0	0	0↓13.2%	1↑102753.9%	7↑475.5%
Total Current Assets	0	0	0↑793.1%	1↑204.2%	7↑454.5%
Total Assets	0	0↓11.4%	5↑9696.4%	1↓72.3%	7↑454.5%
Total Current Liabilities	0	1↑613.8%	1↑35.5%	1↓49.0%	1↑109.7%
Total Liabilities	0	1↑613.8%	1↑35.5%	1↓49.0%	1↑109.7%
Total Equity	-0	-1↓1027.5%	3↑466.8%	1↓81.3%	6↑819.6%
Total Debt	0	1	0↓82.6%	0↓7.5%	0
Net Debt	0	1	0↓82.8%	-1↓1275.4%	-7↓521.4%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	-0	-0↓292.5%	-4↓723.6%	-5↓31.4%	-4↑27.3%
Capital Expenditure	-0	0	-0	0	0
Free Cash Flow	-0	-0↓292.5%	-4↓723.6%	-5↓31.4%	-4↑27.3%
Stock-Based Comp	0	0	0	7	5↓23.0%
Net Change in Cash	0	0	-0↓113.2%	1↑672919.1%	6↑376.0%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance